{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:58:43Z","timestamp":1791845923485,"version":"4.3.4"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"University of Wyoming (UWYO) and School of Pharmacy","award":["Startup funds"],"award-info":[{"award-number":["Startup funds"]}]},{"name":"RF Research Foundation and the City University of New York (CUNY) Queens College","award":["Startup funds"],"award-info":[{"award-number":["Startup funds"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10822-025-00730-0","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T03:20:58Z","timestamp":1766114458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chasing allosteric inhibition of the SARS-CoV-2 PLpro via molecular dynamics simulations with flooding fragments (MDFFr)"],"prefix":"10.1007","volume":"40","author":[{"given":"Jason","family":"Pattis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Elokely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Gianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"730_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.antiviral.2017.11.001","volume":"149","author":"J Lei","year":"2018","unstructured":"Lei J, Kusov Y, Hilgenfeld R (2018) Nsp3 of coronaviruses: structures and functions of a large multi-domain protein. Antiviral Res 149:58\u201374. https:\/\/doi.org\/10.1016\/j.antiviral.2017.11.001","journal-title":"Antiviral Res"},{"key":"730_CR2","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1111\/febs.12936","volume":"281","author":"R Hilgenfeld","year":"2014","unstructured":"Hilgenfeld R (2014) From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design. FEBS J 281:4085\u20134096. https:\/\/doi.org\/10.1111\/febs.12936","journal-title":"FEBS J"},{"key":"730_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-022-03090-9","volume":"5","author":"A Narayanan","year":"2022","unstructured":"Narayanan A, Narwal M, Majowicz SA et al (2022) Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay. Commun Biol 5:1\u201317","journal-title":"Commun Biol"},{"key":"730_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.24.15189-15198.2005","author":"N Barretto","year":"2005","unstructured":"Barretto N, Jukneliene D, Ratia K et al (2005) The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol. https:\/\/doi.org\/10.1128\/JVI.79.24.15189-15198.2005","journal-title":"J Virol"},{"key":"730_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.abb.2007.07.006","volume":"466","author":"HA Lindner","year":"2007","unstructured":"Lindner HA, Lytvyn V, Qi H et al (2007) Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch Biochem Biophys 466:8\u201314","journal-title":"Arch Biochem Biophys"},{"key":"730_CR6","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang H-H et al (2020) An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med 26:1636\u20131643","journal-title":"Nat Med"},{"key":"730_CR7","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","volume":"587","author":"D Shin","year":"2020","unstructured":"Shin D, Mukherjee R, Grewe D et al (2020) Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 587:657\u2013662","journal-title":"Nature"},{"key":"730_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd4596","author":"W Rut","year":"2020","unstructured":"Rut W, Lv Z, Zmudzinski M et al (2020) Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: a framework for anti-COVID-19 drug design. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abd4596","journal-title":"Sci Adv"},{"key":"730_CR9","doi-asserted-by":"publisher","first-page":"13600","DOI":"10.1128\/jvi.78.24.13600-13612.2004","volume":"78","author":"BH Harcourt","year":"2004","unstructured":"Harcourt BH, Jukneliene D, Kanjanahaluethai A et al (2004) Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol 78:13600\u201313612. https:\/\/doi.org\/10.1128\/jvi.78.24.13600-13612.2004","journal-title":"J Virol"},{"key":"730_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","volume":"115","author":"YM B\u00e1ez-Santos","year":"2015","unstructured":"B\u00e1ez-Santos YM, St. John SE, Mesecar AD (2015) The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Antiviral Res 115:21\u201338. https:\/\/doi.org\/10.1016\/j.antiviral.2014.12.015","journal-title":"Antiviral Res"},{"key":"730_CR11","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","volume":"12","author":"J Osipiuk","year":"2021","unstructured":"Osipiuk J, Azizi SA, Dvorkin S et al (2021) Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat Commun 12:743","journal-title":"Nat Commun"},{"key":"730_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","volume":"11","author":"X Gao","year":"2021","unstructured":"Gao X, Qin B, Chen P et al (2021) Crystal structure of SARS-CoV-2 papain-like protease. Acta Pharm Sin B 11:237\u2013245. https:\/\/doi.org\/10.1016\/j.apsb.2020.08.014","journal-title":"Acta Pharm Sin B"},{"key":"730_CR13","doi-asserted-by":"publisher","first-page":"32208","DOI":"10.1074\/jbc.M704870200","volume":"282","author":"SG Devaraj","year":"2007","unstructured":"Devaraj SG, Wang N, Chen Z et al (2007) Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus *. J Biol Chem 282:32208\u201332221. https:\/\/doi.org\/10.1074\/jbc.M704870200","journal-title":"J Biol Chem"},{"key":"730_CR14","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1128\/jvi.02406-09","volume":"84","author":"MA Clementz","year":"2010","unstructured":"Clementz MA, Chen Z, Banach BS et al (2010) Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol 84:4619\u20134629. https:\/\/doi.org\/10.1128\/jvi.02406-09","journal-title":"J Virol"},{"key":"730_CR15","doi-asserted-by":"publisher","first-page":"6689","DOI":"10.1128\/jvi.02220-08","volume":"83","author":"M Frieman","year":"2009","unstructured":"Frieman M, Ratia K, Johnston RE et al (2009) Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-\u03baB signaling. J Virol 83:6689\u20136705. https:\/\/doi.org\/10.1128\/jvi.02220-08","journal-title":"J Virol"},{"key":"730_CR16","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01307","author":"Z Shen","year":"2021","unstructured":"Shen Z, Ratia K, Cooper L et al (2021) Design of SARS-CoV-2 PLpro inhibitors for COVID-19 antiviral therapy leveraging binding cooperativity. J Med Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c01307","journal-title":"J Med Chem"},{"key":"730_CR17","doi-asserted-by":"publisher","first-page":"16119","DOI":"10.1073\/pnas.0805240105","volume":"105","author":"K Ratia","year":"2008","unstructured":"Ratia K, Pegan S, Takayama J et al (2008) A noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A 105:16119\u201316124. https:\/\/doi.org\/10.1073\/pnas.0805240105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"730_CR18","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/nature03193","volume":"432","author":"C Lipinski","year":"2004","unstructured":"Lipinski C, Hopkins A (2004) Navigating chemical space for biology and medicine. Nature 432:855\u2013861","journal-title":"Nature"},{"key":"730_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1021\/ci800324m","volume":"49","author":"TA Halgren","year":"2009","unstructured":"Halgren TA (2009) Identifying and characterizing binding sites and assessing druggability. J Chem Inf Model 49:377\u2013389. https:\/\/doi.org\/10.1021\/ci800324m","journal-title":"J Chem Inf Model"},{"key":"730_CR20","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/s41467-023-37254-w","volume":"14","author":"BC Sanders","year":"2023","unstructured":"Sanders BC, Pokhrel S, Labbe AD et al (2023) Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2. Nat Commun 14:1733. https:\/\/doi.org\/10.1038\/s41467-023-37254-w","journal-title":"Nat Commun"},{"key":"730_CR21","doi-asserted-by":"publisher","first-page":"10169","DOI":"10.1038\/s41467-024-54462-0","volume":"15","author":"Y Lu","year":"2024","unstructured":"Lu Y, Yang Q, Ran T et al (2024) Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19. Nat Commun 15:10169. https:\/\/doi.org\/10.1038\/s41467-024-54462-0","journal-title":"Nat Commun"},{"key":"730_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109754","volume":"36","author":"S Patchett","year":"2021","unstructured":"Patchett S, Lv Z, Rut W et al (2021) A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease. Cell Rep 36:109754","journal-title":"Cell Rep"},{"key":"730_CR23","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s42003-022-03737-7","volume":"5","author":"V Srinivasan","year":"2022","unstructured":"Srinivasan V, Brognaro H, Prabhu PR et al (2022) Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease. Commun Biol 5:805","journal-title":"Commun Biol"},{"key":"730_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/bioinformatics\/btp036","volume":"25","author":"R Brenke","year":"2009","unstructured":"Brenke R, Kozakov D, Chuang G-Y et al (2009) Fragment-based identification of druggable \u2018hot spots\u2019 of proteins using Fourier domain correlation techniques. Bioinformatics 25:621\u2013627. https:\/\/doi.org\/10.1093\/bioinformatics\/btp036","journal-title":"Bioinformatics"},{"key":"730_CR25","doi-asserted-by":"publisher","first-page":"5674","DOI":"10.1021\/jm030242k","volume":"46","author":"RJ Zauhar","year":"2003","unstructured":"Zauhar RJ, Moyna G, Tian L et al (2003) Shape signatures: a new approach to computer-aided ligand- and receptor-based drug design. J Med Chem 46:5674\u20135690. https:\/\/doi.org\/10.1021\/jm030242k","journal-title":"J Med Chem"},{"key":"730_CR26","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1021\/ci800219h","volume":"48","author":"E Gianti","year":"2008","unstructured":"Gianti E, Sartori L (2008) Identification and selection of \u201cprivileged fragments\u201d suitable for primary screening. J Chem Inf Model 48:2129\u20132139. https:\/\/doi.org\/10.1021\/ci800219h","journal-title":"J Chem Inf Model"},{"key":"730_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10822-016-9899-y","volume":"30","author":"E Gianti","year":"2016","unstructured":"Gianti E, Messick TE, Lieberman PM, Zauhar RJ (2016) Computational analysis of EBNA1 \u201cdruggability\u201d suggests novel insights for Epstein-Barr virus inhibitor design. J Comput Aided Mol Des 30:285\u2013303. https:\/\/doi.org\/10.1007\/s10822-016-9899-y","journal-title":"J Comput Aided Mol Des"},{"key":"730_CR28","volume-title":"Fragment-based drug discovery: lessons and outlook","author":"DA Erlanson","year":"2015","unstructured":"Erlanson DA, Jahnke W (2015) Fragment-based drug discovery: lessons and outlook. John Wiley & Sons, Hoboken"},{"key":"730_CR29","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1021\/jm040031v","volume":"47","author":"DA Erlanson","year":"2004","unstructured":"Erlanson DA, McDowell RS, O\u2019Brien T (2004) Fragment-based drug discovery. J Med Chem 47:3463\u20133482. https:\/\/doi.org\/10.1021\/jm040031v","journal-title":"J Med Chem"},{"key":"730_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drudis.2011.08.002","volume":"17","author":"G Bottegoni","year":"2012","unstructured":"Bottegoni G, Favia AD, Recanatini M, Cavalli A (2012) The role of fragment-based and computational methods in polypharmacology. Drug Discov Today 17:23\u201334. https:\/\/doi.org\/10.1016\/j.drudis.2011.08.002","journal-title":"Drug Discov Today"},{"key":"730_CR31","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.drudis.2020.06.023","volume":"25","author":"M Bissaro","year":"2020","unstructured":"Bissaro M, Sturlese M, Moro S (2020) The rise of molecular simulations in fragment-based drug design (FBDD): an overview. Drug Discov Today 25:1693\u20131701. https:\/\/doi.org\/10.1016\/j.drudis.2020.06.023","journal-title":"Drug Discov Today"},{"key":"730_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2020.00093","author":"LR de Souza Neto","year":"2020","unstructured":"de Souza Neto LR, Moreira-Filho JT, Neves BJ et al (2020) In silico strategies to support fragment-to-lead optimization in drug discovery. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2020.00093","journal-title":"Front Chem"},{"key":"730_CR33","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1021\/acs.jcim.1c00134","volume":"61","author":"K Yanagisawa","year":"2021","unstructured":"Yanagisawa K, Moriwaki Y, Terada T, Shimizu K (2021) EXPRORER: rational cosolvent set construction method for cosolvent molecular dynamics using large-scale computation. J Chem Inf Model 61:2744\u20132753. https:\/\/doi.org\/10.1021\/acs.jcim.1c00134","journal-title":"J Chem Inf Model"},{"key":"730_CR34","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1021\/ct300117j","volume":"8","author":"A Bakan","year":"2012","unstructured":"Bakan A, Nevins N, Lakdawala AS, Bahar I (2012) Druggability assessment of allosteric proteins by dynamics simulations in the presence of probe molecules. J Chem Theory Comput 8:2435\u20132447. https:\/\/doi.org\/10.1021\/ct300117j","journal-title":"J Chem Theory Comput"},{"key":"730_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55394-2","volume":"9","author":"FS Zariquiey","year":"2019","unstructured":"Zariquiey FS, Souza JVde, Bronowska AK (2019) Cosolvent analysis toolkit (CAT): a robust hotspot identification platform for cosolvent simulations of proteins to expand the druggable proteome. Sci Rep 9:19118. https:\/\/doi.org\/10.1038\/s41598-019-55394-2","journal-title":"Sci Rep"},{"key":"730_CR36","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1021\/ci4005628","volume":"53","author":"EP Raman","year":"2013","unstructured":"Raman EP, Yu W, Lakkaraju SK, MacKerell AD Jr (2013) Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach. J Chem Inf Model 53:3384\u20133398. https:\/\/doi.org\/10.1021\/ci4005628","journal-title":"J Chem Inf Model"},{"key":"730_CR37","doi-asserted-by":"publisher","first-page":"8685","DOI":"10.1021\/acs.jpcb.6b03515","volume":"120","author":"P Ghanakota","year":"2016","unstructured":"Ghanakota P, Carlson HA (2016) Moving beyond active-site detection: MixMD applied to allosteric systems. J Phys Chem B 120:8685\u20138695. https:\/\/doi.org\/10.1021\/acs.jpcb.6b03515","journal-title":"J Phys Chem B"},{"key":"730_CR38","doi-asserted-by":"publisher","first-page":"10383","DOI":"10.1021\/acs.jmedchem.6b00399","volume":"59","author":"P Ghanakota","year":"2016","unstructured":"Ghanakota P, Carlson HA (2016) Driving structure-based drug discovery through cosolvent molecular dynamics. J Med Chem 59:10383\u201310399. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00399","journal-title":"J Med Chem"},{"key":"730_CR39","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1021\/acs.jcim.8b00925","volume":"59","author":"P Ghanakota","year":"2019","unstructured":"Ghanakota P, DasGupta D, Carlson HA (2019) Free energies and entropies of binding sites identified by MixMD cosolvent simulations. J Chem Inf Model 59:2035\u20132045. https:\/\/doi.org\/10.1021\/acs.jcim.8b00925","journal-title":"J Chem Inf Model"},{"key":"730_CR40","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1021\/acs.jcim.0c01002","volume":"61","author":"RD Smith","year":"2021","unstructured":"Smith RD, Carlson HA (2021) Identification of cryptic binding sites using MixMD with standard and accelerated molecular dynamics. J Chem Inf Model 61:1287\u20131299. https:\/\/doi.org\/10.1021\/acs.jcim.0c01002","journal-title":"J Chem Inf Model"},{"key":"730_CR41","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1021\/acs.jcim.8b00265","volume":"58","author":"SE Graham","year":"2018","unstructured":"Graham SE, Leja N, Carlson HA (2018) MixMD probeview: robust binding site prediction from cosolvent simulations. J Chem Inf Model 58:1426. https:\/\/doi.org\/10.1021\/acs.jcim.8b00265","journal-title":"J Chem Inf Model"},{"key":"730_CR42","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrd3926-c1","volume":"12","author":"H Jhoti","year":"2013","unstructured":"Jhoti H, Williams G, Rees DC, Murray CW (2013) The \u201crule of three\u201d for fragment-based drug discovery: where are we now? Nat Rev Drug Discov 12:644\u2013644. https:\/\/doi.org\/10.1038\/nrd3926-c1","journal-title":"Nat Rev Drug Discov"},{"key":"730_CR43","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1529\/biophysj.107.119958","volume":"94","author":"S Vemparala","year":"2008","unstructured":"Vemparala S, Domene C, Klein ML (2008) Interaction of anesthetics with open and closed conformations of a potassium channel studied via molecular dynamics and normal mode analysis. Biophys J 94:4260\u20134269. https:\/\/doi.org\/10.1529\/biophysj.107.119958","journal-title":"Biophys J"},{"key":"730_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003090","volume":"9","author":"SG Raju","year":"2013","unstructured":"Raju SG, Barber AF, LeBard DN et al (2013) Exploring volatile general anesthetic binding to a closed membrane-bound bacterial voltage-gated sodium channel via computation. PLoS Comput Biol 9:e1003090. https:\/\/doi.org\/10.1371\/journal.pcbi.1003090","journal-title":"PLoS Comput Biol"},{"key":"730_CR45","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1085\/jgp.201711924","volume":"150","author":"E Yang","year":"2018","unstructured":"Yang E, Granata D, Eckenhoff RG et al (2018) Propofol inhibits prokaryotic voltage-gated Na+ channels by promoting activation-coupled inactivation. J Gen Physiol 150:1299\u20131316. https:\/\/doi.org\/10.1085\/jgp.201711924","journal-title":"J Gen Physiol"},{"key":"730_CR46","doi-asserted-by":"publisher","first-page":"6726","DOI":"10.1073\/pnas.1405768111","volume":"111","author":"AF Barber","year":"2014","unstructured":"Barber AF, Carnevale V, Klein ML et al (2014) Modulation of a voltage-gated Na+ channel by sevoflurane involves multiple sites and distinct mechanisms. Proc Natl Acad Sci USA 111:6726\u20136731. https:\/\/doi.org\/10.1073\/pnas.1405768111","journal-title":"Proc Natl Acad Sci USA"},{"key":"730_CR47","doi-asserted-by":"publisher","first-page":"W522","DOI":"10.1093\/nar\/gkm276","volume":"35","author":"TJ Dolinsky","year":"2007","unstructured":"Dolinsky TJ, Czodrowski P, Li H et al (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 35:W522\u2013W525. https:\/\/doi.org\/10.1093\/nar\/gkm276","journal-title":"Nucleic Acids Res"},{"key":"730_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R et al (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"730_CR49","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD et al (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926. https:\/\/doi.org\/10.1063\/1.445869","journal-title":"J Chem Phys"},{"key":"730_CR50","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182\u20137190. https:\/\/doi.org\/10.1063\/1.328693","journal-title":"J Appl Phys"},{"key":"730_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang J, Rauscher S, Nawrocki G et al (2017) CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat Methods 14:71\u201373. https:\/\/doi.org\/10.1038\/nmeth.4067","journal-title":"Nat Methods"},{"key":"730_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21367","author":"K Vanommeslaeghe","year":"2009","unstructured":"Vanommeslaeghe K, Hatcher E, Acharya C et al (2009) CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem. https:\/\/doi.org\/10.1002\/jcc.21367","journal-title":"J Comput Chem"},{"key":"730_CR53","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1021\/ci300363c","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe K, MacKerell AD Jr (2012) Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing. J Chem Inf Model 52:3144\u20133154. https:\/\/doi.org\/10.1021\/ci300363c","journal-title":"J Chem Inf Model"},{"key":"730_CR54","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1021\/ci3003649","volume":"52","author":"K Vanommeslaeghe","year":"2012","unstructured":"Vanommeslaeghe K, Raman EP, MacKerell AD Jr (2012) Automation of the CHARMM general force field (CGenFF) II: assignment of bonded parameters and partial atomic charges. J Chem Inf Model 52:3155\u20133168. https:\/\/doi.org\/10.1021\/ci3003649","journal-title":"J Chem Inf Model"},{"key":"730_CR55","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.bpj.2015.08.015","volume":"109","author":"RT McGibbon","year":"2015","unstructured":"McGibbon RT, Beauchamp KA, Harrigan MP et al (2015) MDTraj: a modern open library for the analysis of molecular dynamics trajectories. Biophys J 109:1528\u20131532","journal-title":"Biophys J"},{"key":"730_CR56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter JD (2007) Matplotlib: a 2D graphics environment. Comput Sci Eng 9:90\u201395","journal-title":"Comput Sci Eng"},{"key":"730_CR57","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1021\/acs.jctc.5b00743","volume":"11","author":"MK Scherer","year":"2015","unstructured":"Scherer MK, Trendelkamp-Schroer B, Paul F et al (2015) PyEMMA 2: a software package for estimation, validation, and analysis of Markov models. J Chem Theory Comput 11:5525\u20135542","journal-title":"J Chem Theory Comput"},{"key":"730_CR58","unstructured":"Ester M, Kriegel H-P, Xu X A density-based algorithm for discovering clusters in large spatial databases with noise"},{"key":"730_CR59","doi-asserted-by":"publisher","DOI":"10.1145\/3068335","volume":"42","author":"E Schubert","year":"2017","unstructured":"Schubert E, Sander J, Ester M et al (2017) DBSCAN revisited, revisited: why and how you should (still) use DBSCAN. ACM Trans Database Syst 42:19:1-19:21. https:\/\/doi.org\/10.1145\/3068335","journal-title":"ACM Trans Database Syst"},{"key":"730_CR60","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A et al (2011) Scikit-learn: Machine Learning in Python. J Mach Learn Res 12:2825\u20132830","journal-title":"J Mach Learn Res"},{"issue":"33\u201338","key":"730_CR61","first-page":"27","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14(33\u201338):27\u201328","journal-title":"J Mol Graph"},{"key":"730_CR62","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1093\/bioinformatics\/btr550","volume":"27","author":"P Schmidtke","year":"2011","unstructured":"Schmidtke P, Bidon-Chanal A, Luque FJ, Barril X (2011) MDpocket: open-source cavity detection and characterization on molecular dynamics trajectories. Bioinformatics 27:3276\u20133285. https:\/\/doi.org\/10.1093\/bioinformatics\/btr550","journal-title":"Bioinformatics"},{"key":"730_CR63","doi-asserted-by":"publisher","first-page":"4941","DOI":"10.1021\/j100349a053","volume":"93","author":"JCI Tanger","year":"1989","unstructured":"Tanger JCI, Pitzer KS (1989) Calculation of the thermodynamic properties of aqueous electrolytes to 1000.degree.C and 5000 bar from a semicontinuum model for ion hydration. J Phys Chem 93:4941\u20134951. https:\/\/doi.org\/10.1021\/j100349a053","journal-title":"J Phys Chem"},{"key":"730_CR64","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1021\/j100161a002","volume":"95","author":"AA Rashin","year":"1991","unstructured":"Rashin AA, Bukatin MA (1991) Continuum based calculations of hydration entropies and the hydrophobic effect. J Phys Chem 95:2942\u20132944. https:\/\/doi.org\/10.1021\/j100161a002","journal-title":"J Phys Chem"},{"key":"730_CR65","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/jcc.1032","volume":"22","author":"JA Grant","year":"2001","unstructured":"Grant JA, Pickup BT, Nicholls A (2001) A smooth permittivity function for Poisson-Boltzmann solvation methods. J Comput Chem 22:608\u2013640. https:\/\/doi.org\/10.1002\/jcc.1032","journal-title":"J Comput Chem"},{"key":"730_CR66","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.bpj.2018.11.3144","volume":"116","author":"JR Porter","year":"2019","unstructured":"Porter JR, Moeder KE, Sibbald CA et al (2019) Cooperative changes in solvent exposure identify cryptic pockets, switches, and allosteric coupling. Biophys J 116:818\u2013830","journal-title":"Biophys J"},{"key":"730_CR67","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1126\/science.1136800","volume":"315","author":"BJ Frey","year":"2007","unstructured":"Frey BJ, Dueck D (2007) Clustering by passing messages between data points. Science 315:972\u2013976. https:\/\/doi.org\/10.1126\/science.1136800","journal-title":"Science"},{"key":"730_CR68","doi-asserted-by":"publisher","first-page":"13528","DOI":"10.1073\/pnas.1101835108","volume":"108","author":"D Kozakov","year":"2011","unstructured":"Kozakov D, Hall DR, Chuang G-Y et al (2011) Structural conservation of druggable hot spots in protein\u2013protein interfaces. Proc Natl Acad Sci 108:13528\u201313533. https:\/\/doi.org\/10.1073\/pnas.1101835108","journal-title":"Proc Natl Acad Sci"},{"key":"730_CR69","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/s41467-025-56902-x","volume":"16","author":"P Jadhav","year":"2025","unstructured":"Jadhav P, Liang X, Ansari A et al (2025) Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates. Nat Commun 16:1604. https:\/\/doi.org\/10.1038\/s41467-025-56902-x","journal-title":"Nat Commun"},{"key":"730_CR70","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1021\/acscentsci.1c00519","volume":"7","author":"C Ma","year":"2021","unstructured":"Ma C, Sacco MD, Xia Z et al (2021) Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and a flipGFP-based reporter assay. ACS Cent Sci 7:1245\u20131260. https:\/\/doi.org\/10.1021\/acscentsci.1c00519","journal-title":"ACS Cent Sci"},{"key":"730_CR71","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1126\/science.adm9724","volume":"383","author":"B Tan","year":"2024","unstructured":"Tan B, Zhang X, Ansari A et al (2024) Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model. Science 383:1434\u20131440. https:\/\/doi.org\/10.1126\/science.adm9724","journal-title":"Science"},{"key":"730_CR72","doi-asserted-by":"publisher","first-page":"14918","DOI":"10.1074\/jbc.274.21.14918","volume":"274","author":"J Herold","year":"1999","unstructured":"Herold J, Siddell SG, Gorbalenya AE (1999) A human RNA viral cysteine proteinase that depends upon a unique Zn2+-binding finger connecting the two domains of a papain-like fold *. J Biol Chem 274:14918\u201314925. https:\/\/doi.org\/10.1074\/jbc.274.21.14918","journal-title":"J Biol Chem"},{"key":"730_CR73","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106275","volume":"39","author":"T Klemm","year":"2020","unstructured":"Klemm T, Ebert G, Calleja DJ et al (2020) Mechanism and inhibition of the papain\u2010like protease, PLpro, of SARS\u2010CoV\u20102. EMBO J 39:e106275. https:\/\/doi.org\/10.15252\/embj.2020106275","journal-title":"EMBO J"},{"key":"730_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2022.832431","author":"W Ewert","year":"2022","unstructured":"Ewert W, G\u00fcnther S, Miglioli F et al (2022) Hydrazones and thiosemicarbazones targeting protein-protein-interactions of SARS-CoV-2 papain-like protease. Front Chem. https:\/\/doi.org\/10.3389\/fchem.2022.832431","journal-title":"Front Chem"},{"key":"730_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251910","volume":"16","author":"F Sohraby","year":"2021","unstructured":"Sohraby F, Aryapour H (2021) Unraveling the unbinding pathways of SARS-CoV-2 papain-like proteinase known inhibitors by supervised molecular dynamics simulation. PLoS ONE 16:e0251910. https:\/\/doi.org\/10.1371\/journal.pone.0251910","journal-title":"PLoS ONE"},{"key":"730_CR76","doi-asserted-by":"publisher","first-page":"11585","DOI":"10.1038\/s41598-022-15181-y","volume":"12","author":"GM Ferreira","year":"2022","unstructured":"Ferreira GM, Pillaiyar T, Hirata MH et al (2022) Inhibitor induced conformational changes in SARS-COV-2 papain-like protease. Sci Rep 12:11585. https:\/\/doi.org\/10.1038\/s41598-022-15181-y","journal-title":"Sci Rep"},{"key":"730_CR77","doi-asserted-by":"publisher","unstructured":"Vald\u00e9s-Albuernes JL, D\u00edaz-Pico E, Alfaro S, Caballero J (2024) Modeling of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-2 considering the protein flexibility by using molecular dynamics and cross-docking. Front Mol Biosci 11:. https:\/\/doi.org\/10.3389\/fmolb.2024.1374364","DOI":"10.3389\/fmolb.2024.1374364"},{"key":"730_CR78","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nprot.2015.043","volume":"10","author":"D Kozakov","year":"2015","unstructured":"Kozakov D, Grove LE, Hall DR et al (2015) The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins. Nat Protoc 10:733\u2013755. https:\/\/doi.org\/10.1038\/nprot.2015.043","journal-title":"Nat Protoc"},{"key":"730_CR79","doi-asserted-by":"crossref","unstructured":"Choudhary S, Nehul S, Nagaraj SK, et al (2024) Activity profiling of deubiquitinating inhibitors-bound to SARS-CoV-2 papain like protease with antiviral efficacy in murine infection model. 2022.11.11.516107","DOI":"10.1101\/2022.11.11.516107"},{"key":"730_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107821","author":"JC Ferreira","year":"2024","unstructured":"Ferreira JC, Villanueva AJ, Adem KA et al (2024) Identification of novel allosteric sites of SARS-CoV-2 papain-like protease (PLpro) for the development of COVID-19 antivirals. J Biol Chem. https:\/\/doi.org\/10.1016\/j.jbc.2024.107821","journal-title":"J Biol Chem"},{"key":"730_CR81","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.4c01435","author":"N Vithani","year":"2024","unstructured":"Vithani N, Zhang S, Thompson JP et al (2024) Exploration of cryptic pockets using enhanced sampling along normal modes: a case study of KRAS G12D. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.4c01435","journal-title":"J Chem Inf Model"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00730-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-025-00730-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-025-00730-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:06:36Z","timestamp":1766160396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-025-00730-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["730"],"URL":"https:\/\/doi.org\/10.1007\/s10822-025-00730-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7499914\/v1","asserted-by":"object"}]},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"25"}}